Drug recall D-0601-2021
Product
Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institutional, Galway, Ireland. NDC: 67457-196-02
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.
Lots and codes
Lot #: 200906, Exp. Date February 2022
Recall details
- Recalling firm
- Mylan Institutional LLC, Rockford, IL
- Quantity
- 2,131 cartons
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 3, 2021
- Terminated
- October 18, 2022
Related products
- Thiamine Hydrochloride – drug information
- NDC 67457-196 Thiamine Hydrochloride · Thiamine Hydrochloride 100 mg/mL · Mylan Institutional LLC